Pesquisar
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Atualizações Recentes
-
Ultra Short Acting Benzodiazepines Market Forecast 2026–2034: Trends & Insights
According to a newly published market research report by 24LifeSciences, global ultra short-acting benzodiazepines market was valued at USD 2.4 billion in 2025 and is projected to reach USD 3.7 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period 2025–2034.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15266/ultra-short-acting-benzodiazepines-marketUltra Short Acting Benzodiazepines Market Forecast 2026–2034: Trends & Insights According to a newly published market research report by 24LifeSciences, global ultra short-acting benzodiazepines market was valued at USD 2.4 billion in 2025 and is projected to reach USD 3.7 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period 2025–2034. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15266/ultra-short-acting-benzodiazepines-market0 Comentários 0 Compartilhamentos 5 Visualizações 0 Anterior -
ELISA Protein Stabilizer Market to Grow at a CAGR of 5.2% Through 2032
According to a newly published market research report by 24LifeSciences, global ELISA protein stabilizer market was valued at USD 243.7 million in 2025 and is projected to reach USD 384.9 million by 2034, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period 20262034.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15316/elisa-protein-stabilizer-marketELISA Protein Stabilizer Market to Grow at a CAGR of 5.2% Through 2032 According to a newly published market research report by 24LifeSciences, global ELISA protein stabilizer market was valued at USD 243.7 million in 2025 and is projected to reach USD 384.9 million by 2034, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period 20262034. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15316/elisa-protein-stabilizer-market0 Comentários 0 Compartilhamentos 6 Visualizações 0 Anterior -
Human Brucella ELISA Kits Market to Grow at a CAGR of 5.4% Through 2032
According to a newly published market research report by 24LifeSciences, global Human Brucella ELISA Kits market was valued at USD 75.6 million in 2024 and is projected to reach USD 118.2 million by 2032, growing at a compound annual growth rate (CAGR) of 5.4% during the forecast period 2025–2032.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9627/human-brucella-elisa-kits-marketHuman Brucella ELISA Kits Market to Grow at a CAGR of 5.4% Through 2032 According to a newly published market research report by 24LifeSciences, global Human Brucella ELISA Kits market was valued at USD 75.6 million in 2024 and is projected to reach USD 118.2 million by 2032, growing at a compound annual growth rate (CAGR) of 5.4% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9627/human-brucella-elisa-kits-market0 Comentários 0 Compartilhamentos 9 Visualizações 0 Anterior -
Global Hip Lining Market Growth, Forecast & Key Players
According to a newly published market research report by 24LifeSciences, the global hip lining market was valued at USD 1.8 billion in 2024 and is projected to reach USD 2.9 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period 2025–2032.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/11275/hip-lining-market-marketGlobal Hip Lining Market Growth, Forecast & Key Players According to a newly published market research report by 24LifeSciences, the global hip lining market was valued at USD 1.8 billion in 2024 and is projected to reach USD 2.9 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/11275/hip-lining-market-market0 Comentários 0 Compartilhamentos 19 Visualizações 0 Anterior -
Global Berberine Hydrochloride Tablets Market Growth, Forecast & Key Players
According to a newly published market research report by 24LifeSciences, the global Berberine Hydrochloride Tablets market was valued at USD 1.02 billion in 2024 and is projected to reach USD 1.85 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 20252032.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10525/berberine-hydrochloride-tablets-marketGlobal Berberine Hydrochloride Tablets Market Growth, Forecast & Key Players According to a newly published market research report by 24LifeSciences, the global Berberine Hydrochloride Tablets market was valued at USD 1.02 billion in 2024 and is projected to reach USD 1.85 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 20252032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10525/berberine-hydrochloride-tablets-market0 Comentários 0 Compartilhamentos 19 Visualizações 0 Anterior -
Global Dapoxetine Hydrochloride Drug Substance Market Growth, Forecast & Key Players
According to a newly published market research report by 24LifeSciences, global Dapoxetine Hydrochloride drug substance market was valued at USD 84 million in 2024 and is projected to reach USD 110 million by 2031, growing at a compound annual growth rate (CAGR) of 3.8% during the forecast period 2025–2031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8306/dapoxetine-hydrochloride-drug-substance-marketGlobal Dapoxetine Hydrochloride Drug Substance Market Growth, Forecast & Key Players According to a newly published market research report by 24LifeSciences, global Dapoxetine Hydrochloride drug substance market was valued at USD 84 million in 2024 and is projected to reach USD 110 million by 2031, growing at a compound annual growth rate (CAGR) of 3.8% during the forecast period 2025–2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8306/dapoxetine-hydrochloride-drug-substance-market0 Comentários 0 Compartilhamentos 23 Visualizações 0 Anterior -
Global IBS Implant Market Growth, Forecast & Key Players
According to a newly published market research report by 24LifeSciences, global IBS implant market was valued at USD 635.2 million in 2024 and is projected to reach USD 1.01 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 2025–2032.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10091/ibs-implant-marketGlobal IBS Implant Market Growth, Forecast & Key Players According to a newly published market research report by 24LifeSciences, global IBS implant market was valued at USD 635.2 million in 2024 and is projected to reach USD 1.01 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10091/ibs-implant-market0 Comentários 0 Compartilhamentos 28 Visualizações 0 Anterior -
Allergic Rhinitis Medication Market to Reach USD 18.3 Billion by 2034
According to a newly published market research report by 24LifeSciences, global allergic rhinitis medication market was valued at USD 12.5 billion in 2025 and is projected to reach USD 18.3 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025–2034.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15411/allergic-rhinitis-medication-marketAllergic Rhinitis Medication Market to Reach USD 18.3 Billion by 2034 According to a newly published market research report by 24LifeSciences, global allergic rhinitis medication market was valued at USD 12.5 billion in 2025 and is projected to reach USD 18.3 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025–2034. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15411/allergic-rhinitis-medication-market0 Comentários 0 Compartilhamentos 22 Visualizações 0 Anterior -
Timolol Maleate Eye Drop Market to Grow at a CAGR of 6.4% Through 2032
According to a newly published market research report by 24LifeSciences, global Timolol Maleate Eye Drop market was valued at USD 320 million in 2024 and is projected to reach USD 580 million by 2032, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2032.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15231/timolol-maleate-eye-drop-marketTimolol Maleate Eye Drop Market to Grow at a CAGR of 6.4% Through 2032 According to a newly published market research report by 24LifeSciences, global Timolol Maleate Eye Drop market was valued at USD 320 million in 2024 and is projected to reach USD 580 million by 2032, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15231/timolol-maleate-eye-drop-market0 Comentários 0 Compartilhamentos 22 Visualizações 0 Anterior -
Urinary Antispasodics Market Forecast 2026–2034: Trends & Insights
According to a newly published market research report by 24LifeSciences, global urinary antispasmodics market was valued at USD 2.3 billion in 2024 and is projected to reach USD 3.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period 20252032.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/13988/urinary-antispasodics-marketUrinary Antispasodics Market Forecast 2026–2034: Trends & Insights According to a newly published market research report by 24LifeSciences, global urinary antispasmodics market was valued at USD 2.3 billion in 2024 and is projected to reach USD 3.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period 20252032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/13988/urinary-antispasodics-market0 Comentários 0 Compartilhamentos 25 Visualizações 0 Anterior -
Ultrasonic Medicine Permeation Therapy Apparatus Market Forecast 2026–2034: Trends & Insights
According to a newly published market research report by 24LifeSciences, global ultrasonic medicine permeation therapy apparatus market was valued at USD 79.7 million in 2024 and is projected to reach USD 164 million by 2031, growing at a compound annual growth rate (CAGR) of 11.2% during the forecast period 20252031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15972/ultrasonic-medicine-permeation-therapy-apparatus-market
Ultrasonic Medicine Permeation Therapy Apparatus Market Forecast 2026–2034: Trends & Insights According to a newly published market research report by 24LifeSciences, global ultrasonic medicine permeation therapy apparatus market was valued at USD 79.7 million in 2024 and is projected to reach USD 164 million by 2031, growing at a compound annual growth rate (CAGR) of 11.2% during the forecast period 20252031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15972/ultrasonic-medicine-permeation-therapy-apparatus-market0 Comentários 0 Compartilhamentos 25 Visualizações 0 Anterior -
Persistent Facial Erythema Treatment Market 6.8% CAGR: Top Companies in 2026
According to a newly published market research report by 24LifeSciences, global persistent facial erythema treatment market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2031, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 20252031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15868/persistent-facial-erythema-treatment-marketPersistent Facial Erythema Treatment Market 6.8% CAGR: Top Companies in 2026 According to a newly published market research report by 24LifeSciences, global persistent facial erythema treatment market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2031, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 20252031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15868/persistent-facial-erythema-treatment-market0 Comentários 0 Compartilhamentos 19 Visualizações 0 Anterior
Mais Stories